Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Dopamine Agonists for Pituitary Adenomas.

Cooper O, Greenman Y.

Front Endocrinol (Lausanne). 2018 Aug 21;9:469. doi: 10.3389/fendo.2018.00469. eCollection 2018. Review.

2.

YesU from Bacillus subtilis preferentially binds fucosylated glycans.

Tiralongo J, Cooper O, Litfin T, Yang Y, King R, Zhan J, Zhao H, Bovin N, Day CJ, Zhou Y.

Sci Rep. 2018 Sep 3;8(1):13139. doi: 10.1038/s41598-018-31241-8.

3.

Silent corticotroph adenomas.

Ben-Shlomo A, Cooper O.

Pituitary. 2018 Apr;21(2):183-193. doi: 10.1007/s11102-018-0864-8. Review.

PMID:
29344907
4.

Altered Pituitary Gland Structure and Function in Posttraumatic Stress Disorder.

Cooper O, Bonert V, Moser F, Mirocha J, Melmed S.

J Endocr Soc. 2017 Apr 13;1(6):577-587. doi: 10.1210/js.2017-00069. eCollection 2017 Jun 1.

5.

Frontline therapy of ovarian cancer: trials and tribulations.

Volpe J, Filipi JG, Cooper OR, Penson RT.

Curr Opin Obstet Gynecol. 2018 Feb;30(1):1-6. doi: 10.1097/GCO.0000000000000434. Review.

PMID:
29251676
6.

Role of tyrosine kinase inhibitors in the treatment of pituitary tumours: from bench to bedside.

Ben-Shlomo A, Cooper O.

Curr Opin Endocrinol Diabetes Obes. 2017 Aug;24(4):301-305. doi: 10.1097/MED.0000000000000344. Review.

7.

Long-Term Endocrine Outcomes Following Endoscopic Endonasal Transsphenoidal Surgery for Acromegaly and Associated Prognostic Factors.

Babu H, Ortega A, Nuno M, Dehghan A, Schweitzer A, Bonert HV, Carmichael JD, Cooper O, Melmed S, Mamelak AN.

Neurosurgery. 2017 Aug 1;81(2):357-366. doi: 10.1093/neuros/nyx020.

PMID:
28368500
8.

Sellar and clival plasmacytomas: case series of 5 patients with systematic review of 65 published cases.

Lee J, Kulubya E, Pressman BD, Mamelak A, Bannykh S, Zada G, Cooper O.

Pituitary. 2017 Jun;20(3):381-392. doi: 10.1007/s11102-017-0799-5. Review.

9.

Uranium-Carbene-Imido Metalla-Allenes: Ancillary-Ligand-Controlled cis-/trans-Isomerisation and Assessment of trans Influence in the R2 C=U(IV) =NR' Unit (R=Ph2 PNSiMe3 ; R'=CPh3 ).

Lu E, Cooper OJ, Tuna F, Wooles AJ, Kaltsoyannis N, Liddle ST.

Chemistry. 2016 Aug 8;22(33):11559-63. doi: 10.1002/chem.201602690. Epub 2016 Jul 13.

PMID:
27405793
10.

Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists.

Greenman Y, Cooper O, Yaish I, Robenshtok E, Sagiv N, Jonas-Kimchi T, Yuan X, Gertych A, Shimon I, Ram Z, Melmed S, Stern N.

Eur J Endocrinol. 2016 Jul;175(1):63-72. doi: 10.1530/EJE-16-0206. Epub 2016 May 5.

PMID:
27150495
11.

Correction: EGR1 functions as a potent repressor of MEF2 transcriptional activity.

Feng Y, Desjardins CA, Cooper O, Kontor A, Nocco SE, Naya FJ.

PLoS One. 2015 Jun 24;10(6):e0131619. doi: 10.1371/journal.pone.0131619. eCollection 2015. No abstract available.

12.

Atmosphere. Challenges of a lowered U.S. ozone standard.

Cooper OR, Langford AO, Parrish DD, Fahey DW.

Science. 2015 Jun 5;348(6239):1096-7. doi: 10.1126/science.aaa5748. No abstract available.

PMID:
26045425
13.

EGR1 Functions as a Potent Repressor of MEF2 Transcriptional Activity.

Feng Y, Desjardins CA, Cooper O, Kontor A, Nocco SE, Naya FJ.

PLoS One. 2015 May 26;10(5):e0127641. doi: 10.1371/journal.pone.0127641. eCollection 2015. Erratum in: PLoS One. 2015;10(6):e0131619.

14.

Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.

Hallett PJ, Deleidi M, Astradsson A, Smith GA, Cooper O, Osborn TM, Sundberg M, Moore MA, Perez-Torres E, Brownell AL, Schumacher JM, Spealman RD, Isacson O.

Cell Stem Cell. 2015 Mar 5;16(3):269-74. doi: 10.1016/j.stem.2015.01.018. Epub 2015 Feb 26.

15.

Silent corticotroph adenomas.

Cooper O.

Pituitary. 2015 Apr;18(2):225-31. doi: 10.1007/s11102-014-0624-3. Review.

16.

CS2 activation at uranium(III) siloxide ate complexes: the effect of a Lewis acidic site.

Camp C, Cooper O, Andrez J, Pécaut J, Mazzanti M.

Dalton Trans. 2015 Feb 14;44(6):2650-6. doi: 10.1039/c4dt02585g.

PMID:
25436831
17.

ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice.

Liu X, Kano M, Araki T, Cooper O, Fukuoka H, Tone Y, Tone M, Melmed S.

Endocrinology. 2015 Jan;156(1):71-9. doi: 10.1210/en.2014-1627.

18.

A structural and functional acromegaly classification.

Cuevas-Ramos D, Carmichael JD, Cooper O, Bonert VS, Gertych A, Mamelak AN, Melmed S.

J Clin Endocrinol Metab. 2015 Jan;100(1):122-31. doi: 10.1210/jc.2014-2468.

19.

Long-term health of dopaminergic neuron transplants in Parkinson's disease patients.

Hallett PJ, Cooper O, Sadi D, Robertson H, Mendez I, Isacson O.

Cell Rep. 2014 Jun 26;7(6):1755-61. doi: 10.1016/j.celrep.2014.05.027. Epub 2014 Jun 6.

20.

Synthesis, characterization, and reactivity of a uranium(VI) carbene imido oxo complex.

Lu E, Cooper OJ, McMaster J, Tuna F, McInnes EJ, Lewis W, Blake AJ, Liddle ST.

Angew Chem Int Ed Engl. 2014 Jun 23;53(26):6696-700. doi: 10.1002/anie.201403892. Epub 2014 May 19.

22.

Multimetallic cooperativity in uranium-mediated CO₂ activation.

Cooper O, Camp C, Pécaut J, Kefalidis CE, Maron L, Gambarelli S, Mazzanti M.

J Am Chem Soc. 2014 May 7;136(18):6716-23. doi: 10.1021/ja5017624. Epub 2014 Apr 23.

PMID:
24712893
23.

Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors.

Cooper O, Mamelak A, Bannykh S, Carmichael J, Bonert V, Lim S, Cook-Wiens G, Ben-Shlomo A.

Endocrine. 2014 Jun;46(2):318-27. doi: 10.1007/s12020-013-0093-x. Epub 2013 Nov 28.

24.

LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction.

Sanders LH, Laganière J, Cooper O, Mak SK, Vu BJ, Huang YA, Paschon DE, Vangipuram M, Sundararajan R, Urnov FD, Langston JW, Gregory PD, Zhang HS, Greenamyre JT, Isacson O, Schüle B.

Neurobiol Dis. 2014 Feb;62:381-6. doi: 10.1016/j.nbd.2013.10.013. Epub 2013 Oct 19.

25.

Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.

Sundberg M, Bogetofte H, Lawson T, Jansson J, Smith G, Astradsson A, Moore M, Osborn T, Cooper O, Spealman R, Hallett P, Isacson O.

Stem Cells. 2013 Aug;31(8):1548-62. doi: 10.1002/stem.1415.

26.

The nature of the U=C double bond: pushing the stability of high-oxidation-state uranium carbenes to the limit.

Cooper OJ, Mills DP, McMaster J, Tuna F, McInnes EJ, Lewis W, Blake AJ, Liddle ST.

Chemistry. 2013 May 27;19(22):7071-83. doi: 10.1002/chem.201300071. Epub 2013 Apr 4.

PMID:
23559370
27.

Bisphosphonate drug holiday: choosing appropriate candidates.

Ro C, Cooper O.

Curr Osteoporos Rep. 2013 Mar;11(1):45-51. doi: 10.1007/s11914-012-0129-9. Review.

28.

Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.

Cooper O, Parmar M, Isacson O.

Prog Brain Res. 2012;200:265-76. doi: 10.1016/B978-0-444-59575-1.00012-0. Review.

PMID:
23195423
29.

Single-surgeon fully endoscopic endonasal transsphenoidal surgery: outcomes in three-hundred consecutive cases.

Mamelak AN, Carmichael J, Bonert VH, Cooper O, Melmed S.

Pituitary. 2013 Sep;16(3):393-401. doi: 10.1007/s11102-012-0437-1.

PMID:
23011322
30.

Ectopic acromegaly due to growth hormone releasing hormone.

Ghazi AA, Amirbaigloo A, Dezfooli AA, Saadat N, Ghazi S, Pourafkari M, Tirgari F, Dhall D, Bannykh S, Melmed S, Cooper O.

Endocrine. 2013 Apr;43(2):293-302. doi: 10.1007/s12020-012-9790-0. Epub 2012 Sep 15. Review.

31.

Learner-controlled practice difficulty in the training of a complex task: cognitive and motivational mechanisms.

Hughes MG, Day EA, Wang X, Schuelke MJ, Arsenault ML, Harkrider LN, Cooper OD.

J Appl Psychol. 2013 Jan;98(1):80-98. doi: 10.1037/a0029821. Epub 2012 Aug 27.

PMID:
22925045
32.

Subclinical hyperfunctioning pituitary adenomas: the silent tumors.

Cooper O, Melmed S.

Best Pract Res Clin Endocrinol Metab. 2012 Aug;26(4):447-60. doi: 10.1016/j.beem.2012.01.002. Epub 2012 May 22. Review.

33.

Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease.

Cooper O, Seo H, Andrabi S, Guardia-Laguarta C, Graziotto J, Sundberg M, McLean JR, Carrillo-Reid L, Xie Z, Osborn T, Hargus G, Deleidi M, Lawson T, Bogetofte H, Perez-Torres E, Clark L, Moskowitz C, Mazzulli J, Chen L, Volpicelli-Daley L, Romero N, Jiang H, Uitti RJ, Huang Z, Opala G, Scarffe LA, Dawson VL, Klein C, Feng J, Ross OA, Trojanowski JQ, Lee VM, Marder K, Surmeier DJ, Wszolek ZK, Przedborski S, Krainc D, Dawson TM, Isacson O.

Sci Transl Med. 2012 Jul 4;4(141):141ra90. doi: 10.1126/scitranslmed.3003985.

34.

Synthesis of a uranium(VI)-carbene: reductive formation of uranyl(V)-methanides, oxidative preparation of a [R2C═U═O]2+ analogue of the [O═U═O]2+ uranyl ion (R = Ph2PNSiMe3), and comparison of the nature of U(IV)═C, U(V)═C, and U(VI)═C double bonds.

Mills DP, Cooper OJ, Tuna F, McInnes EJ, Davies ES, McMaster J, Moro F, Lewis W, Blake AJ, Liddle ST.

J Am Chem Soc. 2012 Jun 20;134(24):10047-54. doi: 10.1021/ja301333f. Epub 2012 Jun 7.

PMID:
22621395
35.

Using stem cells and iPS cells to discover new treatments for Parkinson's disease.

Cooper O, Hallett P, Isacson O.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S14-6. doi: 10.1016/S1353-8020(11)70007-4. Review.

36.
37.

EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.

Fukuoka H, Cooper O, Ben-Shlomo A, Mamelak A, Ren SG, Bruyette D, Melmed S.

J Clin Invest. 2011 Dec;121(12):4712-21. doi: 10.1172/JCI60417. Epub 2011 Nov 21.

38.

Expression and function of ErbB receptors and ligands in the pituitary.

Cooper O, Vlotides G, Fukuoka H, Greene MI, Melmed S.

Endocr Relat Cancer. 2011 Oct 27;18(6):R197-211. doi: 10.1530/ERC-11-0066. Print 2011 Oct. Review.

39.

Oct4-induced reprogramming is required for adult brain neural stem cell differentiation into midbrain dopaminergic neurons.

Deleidi M, Cooper O, Hargus G, Levy A, Isacson O.

PLoS One. 2011;6(5):e19926. doi: 10.1371/journal.pone.0019926. Epub 2011 May 31.

40.

Uranium-carbon multiple bonding: facile access to the pentavalent uranium carbene [U{C(PPh2NSiMe3)2}(Cl)2(I)] and comparison of U(V)=C and U(IV)=C bonds.

Cooper OJ, Mills DP, McMaster J, Moro F, Davies ES, Lewis W, Blake AJ, Liddle ST.

Angew Chem Int Ed Engl. 2011 Mar 1;50(10):2383-6. doi: 10.1002/anie.201007675. Epub 2011 Feb 14. No abstract available.

PMID:
21351360
41.

HER2/ErbB2 receptor signaling in rat and human prolactinoma cells: strategy for targeted prolactinoma therapy.

Fukuoka H, Cooper O, Mizutani J, Tong Y, Ren SG, Bannykh S, Melmed S.

Mol Endocrinol. 2011 Jan;25(1):92-103. doi: 10.1210/me.2010-0353. Epub 2010 Nov 24.

42.

Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats.

Hargus G, Cooper O, Deleidi M, Levy A, Lee K, Marlow E, Yow A, Soldner F, Hockemeyer D, Hallett PJ, Osborn T, Jaenisch R, Isacson O.

Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15921-6. doi: 10.1073/pnas.1010209107. Epub 2010 Aug 23.

43.

Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.

Cooper O, Ben-Shlomo A, Bonert V, Bannykh S, Mirocha J, Melmed S.

Horm Cancer. 2010 Apr;1(2):80-92. doi: 10.1007/s12672-010-0014-x.

44.

Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid.

Cooper O, Hargus G, Deleidi M, Blak A, Osborn T, Marlow E, Lee K, Levy A, Perez-Torres E, Yow A, Isacson O.

Mol Cell Neurosci. 2010 Nov;45(3):258-66. doi: 10.1016/j.mcn.2010.06.017. Epub 2010 Jul 24.

45.

A monomeric dilithio methandiide with a distorted trans-planar four-coordinate carbon.

Cooper OJ, Wooles AJ, McMaster J, Lewis W, Blake AJ, Liddle ST.

Angew Chem Int Ed Engl. 2010 Jul 26;49(32):5570-3. doi: 10.1002/anie.201002483. No abstract available.

PMID:
20589822
46.

Liver tumors segmentation from CTA images using voxels classification and affinity constraint propagation.

Freiman M, Cooper O, Lischinski D, Joskowicz L.

Int J Comput Assist Radiol Surg. 2011 Mar;6(2):247-55. doi: 10.1007/s11548-010-0497-5. Epub 2010 Jun 24.

PMID:
20574799
47.

Synthesis and structure of [U{C(PPh2NMes)2}2] (Mes = 2,4,6-Me3C6H2): A homoleptic uranium bis(carbene) complex with two formal U=C double bonds.

Cooper OJ, McMaster J, Lewis W, Blake AJ, Liddle ST.

Dalton Trans. 2010 Jun 7;39(21):5074-6. doi: 10.1039/c0dt00152j.

PMID:
20401420
48.

Increasing springtime ozone mixing ratios in the free troposphere over western North America.

Cooper OR, Parrish DD, Stohl A, Trainer M, Nédélec P, Thouret V, Cammas JP, Oltmans SJ, Johnson BJ, Tarasick D, Leblanc T, McDermid IS, Jaffe D, Gao R, Stith J, Ryerson T, Aikin K, Campos T, Weinheimer A, Avery MA.

Nature. 2010 Jan 21;463(7279):344-8. doi: 10.1038/nature08708.

PMID:
20090751
49.

No evidence for disease-like processes in fetal transplants.

Hallett PJ, Cooper O, Isacson O.

Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):E104; author reply E105. doi: 10.1073/pnas.0908169106. Epub 2009 Sep 2. No abstract available.

50.

Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients.

Cooper O, Astradsson A, Hallett P, Robertson H, Mendez I, Isacson O.

J Neurol. 2009 Aug;256 Suppl 3:310-6. doi: 10.1007/s00415-009-5242-z. Review.

PMID:
19711122

Supplemental Content

Loading ...
Support Center